Superstar soccer/football player Cristiano Ronaldo will reportedly undergo a stem cell treatment procedure to try to mend a hamstring injury. He is one in a long line of sports stars who are taking this gamble. This is reported by the highly rigorous source, The Daily Mail as well as the Independent. The latter quoted his mother about this situation and her son: “He is like his mother. He has a strong personality, he is very proud and he always demands more. This is his worst …Read More
Editors note: This is a guest post from Caroline Simons who is attending the two Paris meetings on human gene editing. For more background on those meetings see here. By Caroline Simons There were just over a hundred participants at the workshop organized by the Federation of European Academies of Medicine, the UK Academy of Medical Sciences and the Académie Nationale de Médicine France. That number included experts in the fields of science, medicine, law and bioethics. They came from Europe, the US and …Read More
There’s some big, positive news on the stem cell front today. Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of small molecules was able to turn them directly into precursors for heart muscle and neural cells. The two direct reprogramming papers were published in Science here and in Cell Stem Cell here. The former paper is Cao, et al. and the latter is Zhang, …Read More
Over the years, the Vatican has expressed interest and even invested money in the adult stem cell field. Not surprisingly, they’ve also been critical of embryonic stem cell research. Interestingly their own stem cell meetings have at times stimulated heated debate for various reasons and one was even cancelled with at least part of the reason related to embryonic stem cell research.
This week there will be two meetings in Paris as part of the ongoing international dialogue on human genetic modification/human gene editing, CRISPR, and figuring out a wise path forward. A one-day workshop will be held on April 28th “jointly organised by the Federation of European Academies of Medicine (FEAM), the UK Academy of Medical Sciences and the French Academy of Medicine; with kind support from the InterAcademy Partnership for Health and the French Academy Foundation. It will be held at the French Academy …Read More
Have you had a stem cell treatment and if so, what was your experience like? Please also see our 2020 guide and polls on stem cell treatment cost. I really value the diversity of readers on this blog from all over the world. I know we have a lot of readers who are patients and have had stem cell treatments. Every week I get emails from people asking about stem cell treatments and clinics. I encourage you to weigh in here in the comments if you …Read More
Here are some weekend science reads for you. A new type of “magic” mushroom? MIT Tech Review on lack of oversight of new GMO foods coming to your plate. DrugMonkey’s piece on lab labor and specifically whether undergrads “count” drew a lot of comments there. Of course they count in my view.
From a visit to Portland a few weeks back and going to Nectar frozen yogurt. Is this one listening to you or monitoring your diet? I got a combo of chocolate and pistachio instead, which was delicious. This got me thinking of course whether all those folks at the NSA “listening” to us have their very own fro yo service at their commissary so they don’t have to go out for a treat and stop their surveillance. If so what might the most popular flavor …Read More
A new study on treating pain with a unique stem cell connection caught my attention. The paper was from a team at Pfizer led by Edward B. Stevens. Talk about bench to bedside, these researchers went all the way from patients to patient somatic cells to reprogrammed IPSC to neurons to model pain in a dish and then test a drug in a dish, and then finally to test the drug in the patients. The drug in questions is the Nav1.7 blocker, PF-05089771. The team found that …Read More
Some stem cell clinics sometimes use questionable ideas to bypass FDA regulations and I’d go far as to say some of these are outright stem cell myths. One such argument that seems like a myth in my opinion relates to the idea of “homologous use”, which is one of the hottest issues in stem cells in the clinical arena right now. So what is homologous use and what is the clinic myth? The idea with homologous use goes that a stem cell product fitting that definition is similar to …Read More